Pieter van Paassen

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Interstitial Lung Disease

Systemic Sclerosis

Pulmonary Hypertension

Top Venues

Journal of clinical medicine

Diagnostics (Basel, Switzerland)

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Rachid Tobal, Judith Potjewijd, Daan P C van Doorn, Vanessa van Empel, Jan G M C Damoiseaux, Pieter van Paassen
High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary Hypertension. Diagnostics (Basel, Switzerland) 14 (14) (2024)
Rachid Tobal, Judith Potjewijd, Daan P C van Doorn, Vanessa van Empel, Jan G M C Damoiseaux, Pieter van Paassen
High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary Hypertension. Diagnostics (Basel, Switzerland) 14 (14) (2024)
Rachid Tobal, Judith Potjewijd, Daan P C van Doorn, Vanessa van Empel, Jan G M C Damoiseaux, Pieter van Paassen
High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary Hypertension. Diagnostics (Basel, Switzerland) 14 (14) (2024)
Judith Potjewijd, Rachid Tobal, Karin A Boomars, Vanessa V P M van Empel, Femke de Vries, Jan G M C Damoiseaux, Leon J Schurgers, Pieter van Paassen
Plasma Dephosphorylated-Uncarboxylated Matrix Gla-Protein in Systemic Sclerosis Patients: Biomarker Potential for Vascular Calcification and Inflammation. Diagnostics (Basel, Switzerland) 13 (23) (2023)
Matthias H Busch, Sjoerd A M E G Timmermans, Joop P Aendekerk, Renée Ysermans, Jean Amiral, Jan G M C Damoiseaux, Chris P M Reutelingsperger, Pieter van Paassen
Annexin A1 Is Associated with Adverse Clinical Outcomes in Patients with COVID-19. Journal of clinical medicine 11 (24) (2022)
Matthias H Busch, Sjoerd A M E G Timmermans, Joop P Aendekerk, Renée Ysermans, Jean Amiral, Jan G M C Damoiseaux, Chris P M Reutelingsperger, Pieter van Paassen
Annexin A1 Is Associated with Adverse Clinical Outcomes in Patients with COVID-19. Journal of clinical medicine 11 (24) (2022)
Alexander P. J. Vlaar, Endry H T Lim, Sanne de Bruin, Simon Rückinger, Korinna Pilz, Matthijs C Brouwer, Ren-Feng Guo, Leo M A Heunks, Matthias H Busch, Pieter van Paassen, Niels C Riedemann, Diederik van de Beek
The anti-C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID-19. Clinical and translational science 15 (4) (2022)
Matthias H Busch, Sjoerd A M E G Timmermans, Joop P Aendekerk, Renée Ysermans, Jean Amiral, Jan G M C Damoiseaux, Chris P M Reutelingsperger, Pieter van Paassen
Annexin A1 Is Associated with Adverse Clinical Outcomes in Patients with COVID-19. Journal of clinical medicine 11 (24) (2022)
Sjoerd A M E G Timmermans, Pieter van Paassen
The Syndromes of Thrombotic Microangiopathy: A Critical Appraisal on Complement Dysregulation. Journal of clinical medicine 10 (14) (2021)